{"id":46846,"date":"2022-08-02T18:02:24","date_gmt":"2022-08-02T16:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/"},"modified":"2022-08-02T18:02:24","modified_gmt":"2022-08-02T16:02:24","slug":"unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/","title":{"rendered":"UNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF"},"content":{"rendered":"
\n

MONTREAL–(BUSINESS WIRE)–#AIDS2022<\/a>–As the world\u2019s largest HIV\/AIDS conference, AIDS 2022<\/a>, is set to conclude today \u2013 amid a visa scandal that barred many advocates from the most HIV-affected countries in the Global South \u2013 AHF<\/a> calls for UNAIDS and WHO to place a renewed and urgent focus on HIV testing and treatment initiation and retention. Those aspects of the HIV response are sorely lacking from the worrisome UNAIDS report<\/a> released last week.\n<\/p>\n

\n\u201cWhile leaders in the global fight against HIV\/AIDS have touched on some aspects of Test & Treat during the 24th International AIDS Conference, it certainly seems there\u2019s no sense of urgency in identifying new cases and getting and keeping patients enrolled and retained in care globally,\u201d said AHF Chief of Global Advocacy and Policy Terri Ford. \u201cEven though the UNAIDS report shows how much COVID-19 has harmed the HIV\/AIDS response, that cannot be an excuse for neglecting proven Test & Treat initiatives, especially for communities most affected by HIV\/AIDS.\u201d\n<\/p>\n

\nAnother vital and urgent aspect of the HIV response not represented in the UNAIDS report is a focus on late presenters. Late presentation to HIV\/AIDS care presents serious health concerns, such as increased transmission, high healthcare costs, increased mortality, early development of opportunistic infections, and an increased risk of resistance to ART.\n<\/p>\n

\nAccording to the latest UNAIDS data<\/a>, there are an estimated 38.4 million people living with HIV globally. Tragically, every year a staggering 650,000 people still die of AIDS-related causes.\n<\/p>\n

\nGlobal targets for HIV\/AIDS control cannot be achieved until there is a concerted effort to ensure people living with HIV enter care and treatment before their immune systems are severely weakened.\n<\/p>\n

\nAIDS Healthcare Foundation<\/b> (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.6 million people in 45 countries worldwide in the US, Africa, Latin America\/Caribbean, the Asia\/Pacific Region and Europe. We are currently the largest non-profit provider of HIV\/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org<\/a>, find us on Facebook: www.facebook.com\/aidshealth<\/a> and follow us on Twitter: @aidshealthcare<\/a> and Instagram: @aidshealthcare<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nUS MEDIA CONTACT:
\n
Ged Kenslea<\/b>, <\/b>Senior Director, Communications, AHF
\n
+1.323.308.1833 work +1.323.791.5526 mobile
\n
gedk@aidshealth.org<\/a>\n<\/p>\n

\nDenys Nazarov, <\/b>Director of Global Policy & Communications, AHF
\n
+1 323.308.1829
\n
denys.nazarov@ahf.org<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MONTREAL–(BUSINESS WIRE)–#AIDS2022–As the world\u2019s largest HIV\/AIDS conference, AIDS 2022, is set to conclude today \u2013 amid a visa scandal that barred many advocates from the most HIV-affected countries in the Global South \u2013 AHF calls for UNAIDS and WHO to place a renewed and urgent focus on HIV testing and treatment initiation and retention. Those … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46846","6":"format-standard","7":"category-industry"},"yoast_head":"\nUNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MONTREAL–(BUSINESS WIRE)–#AIDS2022–As the world\u2019s largest HIV\/AIDS conference, AIDS 2022, is set to conclude today \u2013 amid a visa scandal that barred many advocates from the most HIV-affected countries in the Global South \u2013 AHF calls for UNAIDS and WHO to place a renewed and urgent focus on HIV testing and treatment initiation and retention. Those ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-02T16:02:24+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"UNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF\",\"datePublished\":\"2022-08-02T16:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\\\/\"},\"wordCount\":398,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\\\/\",\"name\":\"UNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-08-02T16:02:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/","og_locale":"en_US","og_type":"article","og_title":"UNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF - Pharma Trend","og_description":"MONTREAL–(BUSINESS WIRE)–#AIDS2022–As the world\u2019s largest HIV\/AIDS conference, AIDS 2022, is set to conclude today \u2013 amid a visa scandal that barred many advocates from the most HIV-affected countries in the Global South \u2013 AHF calls for UNAIDS and WHO to place a renewed and urgent focus on HIV testing and treatment initiation and retention. Those ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-02T16:02:24+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"UNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF","datePublished":"2022-08-02T16:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/"},"wordCount":398,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/","url":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/","name":"UNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-08-02T16:02:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/unaids-who-must-increase-focus-on-test-treat-late-presenters-says-ahf\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"UNAIDS, WHO Must Increase Focus on Test & Treat, Late Presenters, says AHF"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46846"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46846\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}